References
- Roback JD, Grossman BJ, Harris T, et al. AABB technical manual, 17th ed. Arlington, VA: AABB, 2011:737–40.
- Hendrickson JE, Delaney M. Hemolytic disease of the fetus and newborn: modern practice and future investigations. Transfus Med Rev 2016;30:159–64.
- Fasano RM. Hemolytic disease of the fetus and newborn in the molecular era. Semin Fetal Neonatal Med 2016;21:28–34.
- Srivastava K, Albasri J, Alsuhaibani OM, et al. SCAR: the high-prevalence antigen 013.008 in the Scianna blood group system. Transfusion 2021;61:246–54.
- Brunker PAR, Flegel WA. An update on the Scianna blood group system. Immunohematology 2019;35:48–50.
- DeMarco M, Uhl L, Fields L, et al. Hemolytic disease of the newborn due to the Scianna antibody, anti Sc2. Transfusion 1995;35:58–60.
- Hurstell PJ, Banks J. A case of haemolytic disease of the newborn due to anti-Sc2. Transfus Med 2005;15:48.
- Lemay AS, Tong TN, Branch DR, et al. The first case of severe acute hemolytic transfusion reaction caused by anti-Sc2. Transfusion 2018;58:2506–12.
- Tong TN, Cen S, Branch DR. The monocyte monolayer assay: past, present and future. Transfus Med Rev 2019;33:24–8.